JOSEPH JANKOWSKI: Open Payments
NPI 1700900578 · NEWBERRY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 16 payments from 11 companies in 2025. Trend: 2023 $614 · 2024 $300 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Amgen Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Corcept Therapeutics | 1 | $27 |
| Indivior Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
Products named: CAPLYTA, JARDIANCE, OTEZLA, VRAYLAR, TRELEGY ELLIPTA, Korlym, SUBLOCADE, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
